Comprehensive analysis reveals shifts in clonal mutations in lung adenocarcinoma patients, suggesting genetic evolution patterns.
Fold changes between relative proportions of early and late clonal mutations attributed to specific combined mutational signature types.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: